The global CAR T-Cell Therapy market is projected to grow from US$ 2805.8 million in 2023 to US$ 13510 million by 2029, at a Compound Annual Growth Rate (CAGR) of 29.9% during the forecast period.

CAR T-Cell Therapy Market

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.

Market Analysis and Insights: Global CAR T-Cell Therapy Market

The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.

Report Includes

This report presents an overview of global market for CAR T-Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of CAR T-Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CAR T-Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CAR T-Cell Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global CAR T-Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for CAR T-Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline) and Sorrento Therapeutics(Pipeline), etc.

Scope of CAR T-Cell Therapy Market Report

Report Metric	Details
Report Name	CAR T-Cell Therapy Market
Accounted market size in 2023	US$ 2805.8 million
Forecasted market size in 2029	US$ 13510 million
CAGR	29.9
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	CD19 - Targeted BCMA - Targeted
Segment by Application	Lymphoma Multiple Myeloma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CAR T-Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR T-Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR T-Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is CAR T-Cell Therapy Market growing?

Ans: The CAR T-Cell Therapy Market witnessing a CAGR of 29.9 during the forecast period 2023-2029.

What is the CAR T-Cell Therapy Market size in 2029?

Ans: The CAR T-Cell Therapy Market size in 2029 will be US$ 13510 million.

What is the market share of major companies in CAR T-Cell Therapy Market?

Ans: The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%.

What is the Gilead Sciences share in CAR T-Cell Therapy Market?

Ans: The largest player is Gilead Sciences, with a market share of over 50%.

What is the CAR T-Cell Therapy Market share by region?

Ans: North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%.

What is the CAR T-Cell Therapy Market share by type?

Ans: In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%.

What is the CAR T-Cell Therapy Market share by application?

Ans: In the field of application, the market share of lymphoma exceeds 90%.

Who are the main players in the CAR T-Cell Therapy Market report?

Ans: The main players in the CAR T-Cell Therapy Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)

What are the Application segmentation covered in the CAR T-Cell Therapy Market report?

Ans: The Applications covered in the CAR T-Cell Therapy Market report are Lymphoma, Multiple Myeloma

What are the Type segmentation covered in the CAR T-Cell Therapy Market report?

Ans: The Types covered in the CAR T-Cell Therapy Market report are CD19 - Targeted, BCMA - Targeted

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 CD19 - Targeted

1.2.3 BCMA - Targeted

1.3 Market by Application

1.3.1 Global CAR T-Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Lymphoma

1.3.3 Multiple Myeloma

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR T-Cell Therapy Market Perspective (2018-2029)

2.2 Global CAR T-Cell Therapy Growth Trends by Region

2.2.1 CAR T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2018-2023)

2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2024-2029)

2.3 CAR T-Cell Therapy Market Dynamics

2.3.1 CAR T-Cell Therapy Industry Trends

2.3.2 CAR T-Cell Therapy Market Drivers

2.3.3 CAR T-Cell Therapy Market Challenges

2.3.4 CAR T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue CAR T-Cell Therapy by Players

3.1.1 Global CAR T-Cell Therapy Revenue by Players (2018-2023)

3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2018-2023)

3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of CAR T-Cell Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global CAR T-Cell Therapy Market Concentration Ratio

3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2022

3.5 Global Key Players of CAR T-Cell Therapy Head office and Area Served

3.6 Global Key Players of CAR T-Cell Therapy, Product and Application

3.7 Global Key Players of CAR T-Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-Cell Therapy Breakdown Data by Type

4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2018-2023)

4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029)

5 CAR T-Cell Therapy Breakdown Data by Application

5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2018-2023)

5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America CAR T-Cell Therapy Market Size (2018-2029)

6.2 North America CAR T-Cell Therapy Market Size by Type

6.2.1 North America CAR T-Cell Therapy Market Size by Type (2018-2023)

6.2.2 North America CAR T-Cell Therapy Market Size by Type (2024-2029)

6.2.3 North America CAR T-Cell Therapy Market Share by Type (2018-2029)

6.3 North America CAR T-Cell Therapy Market Size by Application

6.3.1 North America CAR T-Cell Therapy Market Size by Application (2018-2023)

6.3.2 North America CAR T-Cell Therapy Market Size by Application (2024-2029)

6.3.3 North America CAR T-Cell Therapy Market Share by Application (2018-2029)

6.4 North America CAR T-Cell Therapy Market Size by Country

6.4.1 North America CAR T-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America CAR T-Cell Therapy Market Size by Country (2018-2023)

6.4.3 North America CAR T-Cell Therapy Market Size by Country (2024-2029)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe CAR T-Cell Therapy Market Size (2018-2029)

7.2 Europe CAR T-Cell Therapy Market Size by Type

7.2.1 Europe CAR T-Cell Therapy Market Size by Type (2018-2023)

7.2.2 Europe CAR T-Cell Therapy Market Size by Type (2024-2029)

7.2.3 Europe CAR T-Cell Therapy Market Share by Type (2018-2029)

7.3 Europe CAR T-Cell Therapy Market Size by Application

7.3.1 Europe CAR T-Cell Therapy Market Size by Application (2018-2023)

7.3.2 Europe CAR T-Cell Therapy Market Size by Application (2024-2029)

7.3.3 Europe CAR T-Cell Therapy Market Share by Application (2018-2029)

7.4 Europe CAR T-Cell Therapy Market Size by Country

7.4.1 Europe CAR T-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe CAR T-Cell Therapy Market Size by Country (2018-2023)

7.4.3 Europe CAR T-Cell Therapy Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China CAR T-Cell Therapy Market Size (2018-2029)

8.2 China CAR T-Cell Therapy Market Size by Type

8.2.1 China CAR T-Cell Therapy Market Size by Type (2018-2023)

8.2.2 China CAR T-Cell Therapy Market Size by Type (2024-2029)

8.2.3 China CAR T-Cell Therapy Market Share by Type (2018-2029)

8.3 China CAR T-Cell Therapy Market Size by Application

8.3.1 China CAR T-Cell Therapy Market Size by Application (2018-2023)

8.3.2 China CAR T-Cell Therapy Market Size by Application (2024-2029)

8.3.3 China CAR T-Cell Therapy Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia CAR T-Cell Therapy Market Size (2018-2029)

9.2 Asia CAR T-Cell Therapy Market Size by Type

9.2.1 Asia CAR T-Cell Therapy Market Size by Type (2018-2023)

9.2.2 Asia CAR T-Cell Therapy Market Size by Type (2024-2029)

9.2.3 Asia CAR T-Cell Therapy Market Share by Type (2018-2029)

9.3 Asia CAR T-Cell Therapy Market Size by Application

9.3.1 Asia CAR T-Cell Therapy Market Size by Application (2018-2023)

9.3.2 Asia CAR T-Cell Therapy Market Size by Application (2024-2029)

9.3.3 Asia CAR T-Cell Therapy Market Share by Application (2018-2029)

9.4 Asia CAR T-Cell Therapy Market Size by Region

9.4.1 Asia CAR T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia CAR T-Cell Therapy Market Size by Region (2018-2023)

9.4.3 Asia CAR T-Cell Therapy Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis CAR T-Cell Therapy Introduction

11.1.4 Novartis Revenue in CAR T-Cell Therapy Business (2018-2023)

11.1.5 Novartis Recent Developments

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences CAR T-Cell Therapy Introduction

11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Business (2018-2023)

11.2.5 Gilead Sciences Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Introduction

11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2018-2023)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 J & J

11.4.1 J & J Company Details

11.4.2 J & J Business Overview

11.4.3 J & J CAR T-Cell Therapy Introduction

11.4.4 J & J Revenue in CAR T-Cell Therapy Business (2018-2023)

11.4.5 J & J Recent Developments

11.5 JW Therapeutics

11.5.1 JW Therapeutics Company Details

11.5.2 JW Therapeutics Business Overview

11.5.3 JW Therapeutics CAR T-Cell Therapy Introduction

11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Business (2018-2023)

11.5.5 JW Therapeutics Recent Developments

11.6 FOSUNKite

11.6.1 FOSUNKite Company Details

11.6.2 FOSUNKite Business Overview

11.6.3 FOSUNKite CAR T-Cell Therapy Introduction

11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Business (2018-2023)

11.6.5 FOSUNKite Recent Developments

11.7 CARsgen Therapeutics (Pipeline)

11.7.1 CARsgen Therapeutics (Pipeline) Company Details

11.7.2 CARsgen Therapeutics (Pipeline) Business Overview

11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Introduction

11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.7.5 CARsgen Therapeutics (Pipeline) Recent Developments

11.8 Autolus Therapeutics(Pipeline)

11.8.1 Autolus Therapeutics(Pipeline) Company Details

11.8.2 Autolus Therapeutics(Pipeline) Business Overview

11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Introduction

11.8.4 Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.8.5 Autolus Therapeutics(Pipeline) Recent Developments

11.9 Sorrento Therapeutics(Pipeline)

11.9.1 Sorrento Therapeutics(Pipeline) Company Details

11.9.2 Sorrento Therapeutics(Pipeline) Business Overview

11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Introduction

11.9.4 Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.9.5 Sorrento Therapeutics(Pipeline) Recent Developments

11.10 Mustang Bio(Pipeline)

11.10.1 Mustang Bio(Pipeline) Company Details

11.10.2 Mustang Bio(Pipeline) Business Overview

11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Introduction

11.10.4 Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.10.5 Mustang Bio(Pipeline) Recent Developments

11.11 Bluebird Bio(Pipeline)

11.11.1 Bluebird Bio(Pipeline) Company Details

11.11.2 Bluebird Bio(Pipeline) Business Overview

11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Introduction

11.11.4 Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.11.5 Bluebird Bio(Pipeline) Recent Developments

11.12 Cellectis(Pipeline)

11.12.1 Cellectis(Pipeline) Company Details

11.12.2 Cellectis(Pipeline) Business Overview

11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Introduction

11.12.4 Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.12.5 Cellectis(Pipeline) Recent Developments

11.13 Allogene Therapeutics(Pipeline)

11.13.1 Allogene Therapeutics(Pipeline) Company Details

11.13.2 Allogene Therapeutics(Pipeline) Business Overview

11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Introduction

11.13.4 Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.13.5 Allogene Therapeutics(Pipeline) Recent Developments

11.14 Celyad(Pipeline)

11.14.1 Celyad(Pipeline) Company Details

11.14.2 Celyad(Pipeline) Business Overview

11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Introduction

11.14.4 Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)

11.14.5 Celyad(Pipeline) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

CARsgen Therapeutics (Pipeline)

Autolus Therapeutics(Pipeline)

Sorrento Therapeutics(Pipeline)

Mustang Bio(Pipeline)

Bluebird Bio(Pipeline)

Cellectis(Pipeline)

Allogene Therapeutics(Pipeline)

Celyad(Pipeline)

Gilead Sciences

Novartis

List of Tables

Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of CD19 - Targeted

Table 3. Key Players of BCMA - Targeted

Table 4. Global CAR T-Cell Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global CAR T-Cell Therapy Market Share by Region (2018-2023)

Table 8. Global CAR T-Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global CAR T-Cell Therapy Market Share by Region (2024-2029)

Table 10. CAR T-Cell Therapy Market Trends

Table 11. CAR T-Cell Therapy Market Drivers

Table 12. CAR T-Cell Therapy Market Challenges

Table 13. CAR T-Cell Therapy Market Restraints

Table 14. Global CAR T-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global CAR T-Cell Therapy Revenue Share by Players (2018-2023)

Table 16. Global Top CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)

Table 17. Global CAR T-Cell Therapy Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of CAR T-Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of CAR T-Cell Therapy, Product and Application

Table 21. Global Key Players of CAR T-Cell Therapy, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global CAR T-Cell Therapy Revenue Market Share by Type (2018-2023)

Table 25. Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global CAR T-Cell Therapy Revenue Market Share by Type (2024-2029)

Table 27. Global CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global CAR T-Cell Therapy Revenue Share by Application (2018-2023)

Table 29. Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global CAR T-Cell Therapy Revenue Share by Application (2024-2029)

Table 31. North America CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America CAR T-Cell Therapy Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America CAR T-Cell Therapy Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America CAR T-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe CAR T-Cell Therapy Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe CAR T-Cell Therapy Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe CAR T-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)

Table 45. China CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 46. China CAR T-Cell Therapy Market Size by Type (2024-2029) & (US$ Million)

Table 47. China CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 48. China CAR T-Cell Therapy Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia CAR T-Cell Therapy Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia CAR T-Cell Therapy Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia CAR T-Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia CAR T-Cell Therapy Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America CAR T-Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)

Table 63. Novartis Company Details

Table 64. Novartis Business Overview

Table 65. Novartis CAR T-Cell Therapy Product

Table 66. Novartis Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 67. Novartis Recent Developments

Table 68. Gilead Sciences Company Details

Table 69. Gilead Sciences Business Overview

Table 70. Gilead Sciences CAR T-Cell Therapy Product

Table 71. Gilead Sciences Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 72. Gilead Sciences Recent Developments

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Product

Table 76. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Developments

Table 78. J & J Company Details

Table 79. J & J Business Overview

Table 80. J & J CAR T-Cell Therapy Product

Table 81. J & J Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 82. J & J Recent Developments

Table 83. JW Therapeutics Company Details

Table 84. JW Therapeutics Business Overview

Table 85. JW Therapeutics CAR T-Cell Therapy Product

Table 86. JW Therapeutics Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 87. JW Therapeutics Recent Developments

Table 88. FOSUNKite Company Details

Table 89. FOSUNKite Business Overview

Table 90. FOSUNKite CAR T-Cell Therapy Product

Table 91. FOSUNKite Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 92. FOSUNKite Recent Developments

Table 93. CARsgen Therapeutics (Pipeline) Company Details

Table 94. CARsgen Therapeutics (Pipeline) Business Overview

Table 95. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product

Table 96. CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 97. CARsgen Therapeutics (Pipeline) Recent Developments

Table 98. Autolus Therapeutics(Pipeline) Company Details

Table 99. Autolus Therapeutics(Pipeline) Business Overview

Table 100. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product

Table 101. Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 102. Autolus Therapeutics(Pipeline) Recent Developments

Table 103. Sorrento Therapeutics(Pipeline) Company Details

Table 104. Sorrento Therapeutics(Pipeline) Business Overview

Table 105. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product

Table 106. Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 107. Sorrento Therapeutics(Pipeline) Recent Developments

Table 108. Mustang Bio(Pipeline) Company Details

Table 109. Mustang Bio(Pipeline) Business Overview

Table 110. Mustang Bio(Pipeline) CAR T-Cell Therapy Product

Table 111. Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 112. Mustang Bio(Pipeline) Recent Developments

Table 113. Bluebird Bio(Pipeline) Company Details

Table 114. Bluebird Bio(Pipeline) Business Overview

Table 115. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product

Table 116. Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 117. Bluebird Bio(Pipeline) Recent Developments

Table 118. Cellectis(Pipeline) Company Details

Table 119. Cellectis(Pipeline) Business Overview

Table 120. Cellectis(Pipeline) CAR T-Cell Therapy Product

Table 121. Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 122. Cellectis(Pipeline) Recent Developments

Table 123. Allogene Therapeutics(Pipeline) Company Details

Table 124. Allogene Therapeutics(Pipeline) Business Overview

Table 125. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product

Table 126. Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 127. Allogene Therapeutics(Pipeline) Recent Developments

Table 128. Celyad(Pipeline) Company Details

Table 129. Celyad(Pipeline) Business Overview

Table 130. Celyad(Pipeline) CAR T-Cell Therapy Product

Table 131. Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)

Table 132. Celyad(Pipeline) Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global CAR T-Cell Therapy Market Share by Type: 2022 VS 2029

Figure 3. CD19 - Targeted Features

Figure 4. BCMA - Targeted Features

Figure 5. Global CAR T-Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global CAR T-Cell Therapy Market Share by Application: 2022 VS 2029

Figure 7. Lymphoma Case Studies

Figure 8. Multiple Myeloma Case Studies

Figure 9. CAR T-Cell Therapy Report Years Considered

Figure 10. Global CAR T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 11. Global CAR T-Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 12. Global CAR T-Cell Therapy Market Share by Region: 2022 VS 2029

Figure 13. Global CAR T-Cell Therapy Market Share by Players in 2022

Figure 14. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)

Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2022

Figure 16. North America CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 17. North America CAR T-Cell Therapy Market Share by Type (2018-2029)

Figure 18. North America CAR T-Cell Therapy Market Share by Application (2018-2029)

Figure 19. North America CAR T-Cell Therapy Market Share by Country (2018-2029)

Figure 20. United States CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Canada CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe CAR T-Cell Therapy Market Size YoY (2018-2029) & (US$ Million)

Figure 23. Europe CAR T-Cell Therapy Market Share by Type (2018-2029)

Figure 24. Europe CAR T-Cell Therapy Market Share by Application (2018-2029)

Figure 25. Europe CAR T-Cell Therapy Market Share by Country (2018-2029)

Figure 26. Germany CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. France CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. U.K. CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Italy CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Russia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Nordic Countries CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. China CAR T-Cell Therapy Market Size YoY (2018-2029) & (US$ Million)

Figure 33. China CAR T-Cell Therapy Market Share by Type (2018-2029)

Figure 34. China CAR T-Cell Therapy Market Share by Application (2018-2029)

Figure 35. Asia CAR T-Cell Therapy Market Size YoY (2018-2029) & (US$ Million)

Figure 36. Asia CAR T-Cell Therapy Market Share by Type (2018-2029)

Figure 37. Asia CAR T-Cell Therapy Market Share by Application (2018-2029)

Figure 38. Asia CAR T-Cell Therapy Market Share by Region (2018-2029)

Figure 39. Japan CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. South Korea CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. China Taiwan CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. India CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Australia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Size YoY (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Share by Type (2018-2029)

Figure 47. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Share by Application (2018-2029)

Figure 48. Middle East, Africa, and Latin America CAR T-Cell Therapy Market Share by Country (2018-2029)

Figure 49. Brazil CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. Mexico CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Turkey CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Israel CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. GCC Countries CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 56. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 57. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 58. J & J Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 59. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 60. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 61. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 62. Autolus Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 63. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 64. Mustang Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 65. Bluebird Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 66. Cellectis(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 67. Allogene Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 68. Celyad(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions